Inlyta 1Mg Tablet 180/Ea

PID	UOM	Price	Qty

You are not eligible to purchase this product. Please contact your account manager for more information.

Product Information

Description

1.1 First-Line Advanced Renal Cell Carcinoma

INLYTA in combination with avelumab is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
INLYTA in combination with pembrolizumab is indicated for the first-line treatment of patients with advanced RCC.

1.2 Second-Line Advanced Renal Cell Carcinoma

INLYTA as a single agent is indicated for the treatment of advanced RCC after failure of one prior systemic therapy.

Frequently Asked Questions(FAQs)

The cost of Inlyta 1Mg Tablet 180/Ea is available for registerd members only .

Inlyta 1Mg Tablet 180/Ea is manufactured by Pfizer.

You can purchase Inlyta 1Mg Tablet 180/Ea on our website at https://supplies.pipelinemedical.com/Product/Detail/inlyta-1mg-tablet--180-ea-421376